Edwards Lifesciences Appoints New CFO and Director
Ticker: EW · Form: 8-K · Filed: Jun 17, 2024 · CIK: 1099800
| Field | Detail |
|---|---|
| Company | Edwards Lifesciences Corp (EW) |
| Form Type | 8-K |
| Filed Date | Jun 17, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $1.00 |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-change, board-appointment, cfo-appointment
Related Tickers: EW
TL;DR
Edwards Lifesciences just named a new CFO and added a director to the board. Big changes incoming?
AI Summary
Edwards Lifesciences Corporation announced on June 14, 2024, changes in its executive team. The company appointed David E. Wood as its new Chief Financial Officer, effective June 17, 2024. Additionally, the Board of Directors elected Sarah E. Glickman as a new director, also effective June 17, 2024.
Why It Matters
These executive changes could signal a new strategic direction or financial management approach for Edwards Lifesciences, impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Executive appointments and board changes can introduce uncertainty and signal shifts in company strategy, which may affect stock performance.
Key Players & Entities
- Edwards Lifesciences Corporation (company) — Registrant
- David E. Wood (person) — Newly appointed Chief Financial Officer
- Sarah E. Glickman (person) — Newly elected director
- June 17, 2024 (date) — Effective date of appointments
- June 14, 2024 (date) — Date of report
FAQ
Who has been appointed as the new Chief Financial Officer of Edwards Lifesciences?
David E. Wood has been appointed as the new Chief Financial Officer, effective June 17, 2024.
When is the effective date for the new CFO and director appointments?
The appointments are effective as of June 17, 2024.
Who was elected as a new director to the Board of Directors?
Sarah E. Glickman was elected as a new director to the Board of Directors.
What is the exact name of the company filing this report?
The exact name of the registrant is Edwards Lifesciences Corporation.
What is the primary business of Edwards Lifesciences?
Edwards Lifesciences Corporation is in the business of orthopedic, prosthetic & surgical appliances & supplies, SIC code 3842.
Filing Stats: 603 words · 2 min read · ~2 pages · Grade level 11.2 · Accepted 2024-06-17 17:01:17
Key Financial Figures
- $1.00 — ich registered Common Stock, par value $1.00 per share EW New York Stock Exchange
Filing Documents
- ew-20240614.htm (8-K) — 26KB
- 0001099800-24-000054.txt ( ) — 146KB
- ew-20240614.xsd (EX-101.SCH) — 2KB
- ew-20240614_lab.xml (EX-101.LAB) — 21KB
- ew-20240614_pre.xml (EX-101.PRE) — 12KB
- ew-20240614_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. EDWARDS LIFESCIENCES CORPORATION By: /s/ Scott B. Ullem Scott B. Ullem Date: June 17, 2024 Chief Financial Officer 3